Zusammenfassung
Unter dem Begriff der malignen Systemerkrankungen verstehen wir die Neoplasien des lymphoreticulären und myeloischen Gewebes. Besonders in den letzten 10 Jahren wurden die Bemühungen intensiviert, Fragen der Ätiologie, Epidemiologie, histopathologi-schen Klassifikation und klinischen Stadieneinteilung dieser Erkrankungen zu klären, um die Voraussetzungen für verbesserte Behandlungsverfahren, insbesondere auch den adäquaten Einsatz der Strahlentherapie, zu schaffen. Bei den malignen Lymphomen leisteten Arbeiten über die Hodgkinsche Erkrankung Schrittmacherdienste. Sie sind beispielhaft für interdisziplinäres und internationales Teamwork, dokumentiert in einer Reihe von Symposien und Konferenzen, die 1965 in Paris (1966) und Rye/New York (1966), in Ann Arbor (1971), 1972 in Stanford (1973), 1973 in London (1975) und 1976 in San Francisco (1977) abgehalten wurden. Als Ergebnis verfügen wir heute bei der Hodgkinschen Erkrankung über klare Konzepte der histologischen und klinischen Klassifikation und damit über Richtlinien für eine bestmögliche Therapie. Der Fortschritt dokumentiert sich in einer signifikanten Verbesserung der Lebenserwartung und in einem hohen Prozentsatz von Heilungen dieser bis dahin unheilbaren Erkrankung.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsPreview
Unable to display preview. Download preview PDF.
Literatur
Abbatucci JS, van der Werf-Messing B (1975) EORTC Radio-Chemotherapy Cooperative Group. Clinical trial using radiotherapy and chemotherapy in Non-Hodgkin-Lymphoma. Chairman: Abbatucci JS. Study Secretary: van der Werf-Messing B. Protocol 20751, June 1975
Aigner K, Dobroschke J, Schwemmle K (1978) Splenektomie bei malignen Lymphomen aus chirurgischer Sicht. Klinikarzt 7: 888–893
Airlie House Warrenton, Virginia (1975) Invitational workshop for the planning of retrospective and prospective studies to delineate optimal classfications of the Non-Hodg-kin’s lymphomas. September 4–5 (1975)
Andersen V, Weeke E, Killmann SA (1974) Extracorporal irradiation of the blood: clinical applications, Strahlentherapie 148: 603–613
Arndt J (1973) Indikationen und Grenzen der Strahlentherapie bösartiger Neubildungen. Fischer, Stuttgart
Arseneau JC, Canellos GP, Johnson RJ, DeVita VT (1977) Risk of new cancers in patients with Hodgkin’s disease. Cancer 40: 1912–1916
Banfi A, Bonadonna G, Carnevali G, Oldini C, Salvini E (1968) Preferential sites of involvement and spread in malignant lymphomas. Europ J Cancer 4: 319–324
Bauer R (1959) Die Strahlenbehandlung der Hämoblastosen. Strahlenforschung und Krebsbehandlung. Strahlentherapie Sonderbd 43: 223–236
Begemann H, Harwerth H-G (1967) Praktische Hämatologie, 3. Aufl. Thieme, Stuttgart, S 134–139
Begemann H, Theml H (1978) Zur Frage der Splenektomie bei der Lymphogranulomatose (Morbus Hodgkin) — Pathophysiologische und klinische Gesichtspunkte. Klinikarzt 7: 714–724
Begemann H, Rastetter J, Kaboth W (1970) Klinische Hämatologie. Thieme, Stuttgart
Bennett MH (1975) Sclerosis in Hon-Hodgkin’s lymphomata. Brit J Cancer 31, Suppl II: 44–52
Bennett MH, Millet YL (1969) Nodular sclerotic lymphosarcoma, a possible new clinico-pathological entity. Clin Radiol 20: 339
Bitran JD, Kinzie J, Sweet DL, Variakojis D, Griem ML, Golomb HM, Miller JB, Noetzel N, Ultmann JE (1977) Survival of patients with localized histiocytic lymphoma. Cancer 39: 342–346
Bonadonna G, Uslenghi C, Zucali R (1975) Recent trends in the medical treatment of Hodgkin’s disease. Europ J Cancer 11: 251–266
Bopp JH, Günther D (1970) Die Strahlenbehandlung des eosinophilen Granuloms. Strahlentherapie 140: 143–147
Bousser J, Bilski-Pasquier G, Blane C (1967) Vergleichende Untersuchungen zur Behandlung der chronischen myeloischen Leukämie mit Röntgenstrahlen und Myleran. Deutscher Röntgenkongreß 1966. Sonderband zur Strahlentherapie, Teil B: 271–275
Brittinger G, Bartels H, Bremer K, Dühmke E, Gunzer U, König E, Stein H (1976) Klinik der malignen Non-Hodgkin-Lymphome entsprechend der Kiel-Klassifikation: Centrocytisches Lymphom, centroblastisch-centrocytisches Lymphom, lymphobla-stisches Lymphom, immunoblastisches Lymphom. In: Löffler H (Hrsg) Maligne Lymphome und monoklonale Gammopathien. Hämatologie und Bluttransfusion, Bd 18. Lehmann, München, S 211–223
Brittinger G, Bartels H, Bremer K, Burger A, Dühmke E, Gunzer U, König F, Schmalhorst U, Stacher A, Stein H, Theml H, Waldener R (Kieler Lymphomgruppe) (1978) Klinische Bedeutung der Kiel-Klassifikation der malignen Non-Hodgkin-Lymphome. In: Hartwich G (Hrsg) Diagnose und Therapie von Leukämien und malignen Lymphomen. Straube, Erlangen, S 57–66
Brittinger G, Bartels H, Burger A, Dühmke E, Fülle HH, Gunzer U, Heinz R, Huhn D, Löhr GW, Musshoff K, Nowicki L, Pfoch M, Pralle H, Schmalhorst U (Kieler Lymphomgruppe (1979) Grundlagen und bisherige Ergebnisse der prospektiven Studie der Kieler Lymphomgruppe über Non-Hodgkin-Lymphom. In: Stacher A, Höcker P (Hrsg) Lymphknotentumoren. Urban & Schwarzenberg, München Wien Baltimore, S 193–200
Brown TC, Peters MV, Bergsagel DE, Reid J (1975) A retrospective analysis of the clinical results in relation to the Rappaport histological classification. Symposium on Non-Hodgkin’s lymphomata. London, October 8–12, 1973. Brit J Cancer 31, Suppl II: 174–186
Brunner H (1942) Nasopharyngeal fibroma. Ann Otol Rhinol Laryngol 51: 29–65
Bruntsch U, Beersik F, Eigler FW, Grub R, van Lessen H, Löhr GW, Musshoff K, Schmidt CG, Slanina J (1977) Primäre und sekundäre explorative Laparatomie und Splenektomie bei Lymphogranulomatose. Dtsch Med Wochenschr 102:1799–1804
Butler JJ (1971) Relationship of histological findings to survival in Hodgkin’s disease. Cancer Res 31: 1170–1775
Cadman EC, Capizzi RL, Bertino JR (1977) Acute nonlymphocytic leukemia. A delayed complication of Hodgkin’s disease therapy: analysis of 109 cases. Cancer 40: 1280–1296
Canellos GP, Young RC, DeVita VT (1972) Combination chemotherapy for advanced Hodgkin’s disease in relaps following extensive radiotherapy. Clin Pharmacol Ther 13: 750–754
Candios GP, De Vita VT, Young RC, Chabner BA, Schein PS, Johnson RE (1975a) Therapy of advanced lymphocytic lymphoma; a preliminary report of a randomized trial between combination chemotherapy (CVP) and intensive radiotherapy. Brit J Cancer 31, Suppl II: 474–480
Canellos G, De Vita VT, Arseneau JC, Whang-Peng J, Johnson REC (1975b) Second malignancies complicating Hodgkin’s disease in remission. Lancet 2: 947–949
Carbone P-P (1972) Non-Hodgkin’s lymphoma: recent observations on natural history and intensive treatment. Cancer (Philadelphia) 30: 1511–1515
Carbone PP, Kaplan HS, Musshoff K, Smithers IW, Tubiana M (1971) Report of the Hodgkin’s disease staging classification committee. Conference on staging in Hodgkin’s disease. Ann Arbor, April 26–28, 1971. Cancer Res 31: 1860–1861
Carbone PP, Spurr C (1968) Management of patients with malignant lymphoma. A comparative study with cyclophosphamide and vinca alcaloids. Cancer Res 28: 811–822
Chaffey JT, Rosenthal DS, Pinkus G, Helmann S (1975) Advanced lymphosarcoma treated by total body irradiation. Brit J Cancer 31, Suppl II: 441–449
Cheyne C (1971) Histiocytosis X. J. Bone Jt Surg 53 B: 366–382
Chilcote RR, Baehner RL, Hammond D (1976) Septicemia and meningitis in children splenectomized for Hodgkin’s disease. Engl J Med 295: 798–800
Conference on Non-Hodgkin’s lymphomas (San Francisco, Sept. 30-Oct. 2, 1976) Proceedings of the (1977) Jones StE, Godden J (eds). Cancer Treat Rep 935–1227
Conklin R, Alexanian R (1975) Clinical classification of plasma cell myeloma. Arch Int Med 135: 139–143
Cox JD (1978) Central lymphatic irradiation to low dose advanced nodular lympho-reticular tumors (Non-Hodgkin’s lymphoma). Radiology 126: 767–772
Cox JD, Koehl RH, Turner WM, King FM (1974) Irradiation in the local control of malignant lymphoreticular tumors (Non-Hodgkin’s malignant lymphoma). Radiology 112: 179–185
Craft CB (1940) Results with roentgen ray therapy in Hodgkin’s disease. Bull Staff Meet Univ Minn Hosp 11: 391–409
Cronkite EP, Chanana AD, Schnappauf H (1965) Extracorporal irradiation of blood and lymph in animals: its effect on homografts and on lymphoma. New Engl J Med 272: 456–461
Cronkite EP, Jansen CR, Cottier H, Rai K, Sipe CR (1964) Lymphocytic production measured by extracorporal irradiation, cannulation and labeling techniques. Ann NY Acad Sci 113:566–577
Dancot H (1967) Über die Heilungsaussichten bei Lymphosarkomen und Retikulosarkomen durch Bestrahlung (Ergebnisse einer Untersuchung bei 395 Fällen). Deutscher Röntgenkongreß 1966, Teil B, Strahlenbehandlung und Strahlenbiologie. Sonderbände zur Strahlentherapie 64: 283
Dancot H, Feremans W (1974) The curability of lympho- and reticulosarcomas. In: Musshoff K (ed) Recent results in cancer research, vol 46. Springer, Berlin Heidelberg New York, pp 201–205
D’Angio GJ, Evans AE, Mitus A (1959) Roentgentherapy of certain complications of acute leukemia in childhood. Amer J Roentgenol 82: 541–553
Deelmann HT (1956) 1943–1954, zitiert nach Sluiter JFT: De histologie van de ziekte van Brill in haar verschillende phasen. Diss Med Amsterdam
Del Regato JA (1941) Roentgentherapy of lymphosarcomas of the tonsil. Radiation Therapy Tumor Inst Seattle (No 2): 67–76
Desser RK, Golomb HM, Ultmann JE, Ferguson DJ, Moran EM, Griem ML, Vardiman J, Kinzie JJ, Blough R (1977) Prognostic classification of Hodgkin’s disease in pathologic stage III based on anatomic considerations. Blood 49: 883–893
De Vita VT, Serpick AA, Carbone PP (1970) Combination chemotherapy in the treatment of advanced Hodgkin’s disease. Ann Int Med 73: 881–895
Djaldetti M, Devries A, Levi B, Patah T (1962) Haemolytic anaemia in lymphocytic leucaemia. Arch Intern Med 110: 449–455
Dorfman RF (1971) Relationship of histology to site in Hodgkin’s disease. Cancer Res 31: 1786–1793
Ellermann U, Bang O (1908) Experimentelle Leukämie bei Hühnern. Zbl Bakt 46:595–609
Epstein MA, zur Hausen H, Bull G, Rabin H (1975) Pilot experiments with EB virus in owl monkeys. Int J Cancer 15: 17–22
Falk LA, Wolfe LG, Deinhardt F (1971) Oncogenesis of Herpesvirus saimiri in marmosets. Fed Proc 30: 514
Farber S (1941) The nature of “solitary or eosinophilic granuloma” of bone. Amer J Path 17: 625–629
Farhangi M, Osserman EF (1973) The treatment of multiple myeloma. Sem Hematol 10: 149–161
Finkelstein JZ, Dyment PG, Hammond GD (1969) Leukemic infiltration of the testes during bone marrow remission. Pediatrics 43: 1042–1045
Fransilla KO, Kalima TV, Voutilainen A (1967) Histological classification of Hodgkin’s disease. Cancer (Philadelphia) 20: 1594–1601
Freeman C, Berg JW, Cutler SJ (1972) Occurrence and prognosis of extranodal lymphomas. Cancer (Philadelphia) 29: 252–260
Fuks Z, Bagshaw MA (1971) Total skin electron treatment of mycosis fungoides. Radiology 100: 145–150
Fuks Z, Bagshaw MA, Farber ME (1973) Prognostic signs and the management of the mycosis fungoides. Cancer (Philadelphia) 32: 1385–1395
Fuller LM, Gamble JF, Butler JJ (1971) Influence of specific histology and clinical presentation on prognosis in localized Hodgkin’s disease treated with intensive large volume radiotherapy. J Radiol 98: 641–654
Galbraith PR (1967) The mechanism of an action of splenic irradiation in chronic myelogenous leukemia. Canad Med Ass J 96: 1636–1641
Gall EA, Mallory TB (1942) Malignant lymphoma: A clinical-pathological survey of 618 cases. Amer J Path 18: 381–429
Gall EA, Rappaport M (1958) Seminar on diseases of lymph nodes and spleen. In: McDonald JE (ed) Proceedings of 23rd seminar, American Society of Clinical Pathology
Galton DAG (1964) Chronic lymphocytic leukaemia: Its pathogenesis and relationship to lymphosarcoma. In: Roulet FC (ed) Symposium on lymphoreticular tumours in Africa, Paris 1963. Karger, Basel New York, pp 163–172
Gerard-Marchant R, Hamlin I, Lennert K, Rilke F, Stansfeld AG, van Unnik JAM (1974) Classification on Non-Hodgkin’s lymphomas. Lancet 1974 II: 405–408
Gilbert HA, Kagan AR (1978) Modern radiation oncology, Cap IV, Lymphomas. Harper & Row, Hagerstown New York San Fracisco London, pp 397–454
Gilbert R (1939) Radiotherapy in Hodgkin’s disease (malignant granulomatosis): Anatomic and clinical foundations; governing principles; results. Amer J Roentgenol 41: 198–241
Gilbert R, Babaiantz L (1931) Notre méthode de roentgenthérapie de la lymphogranu-lomatose (Hodgkin); résultats éloignés. Acta Radiol (Stockholm) 12: 523–529
Glatstein E, Guernsey IM, Rosenberg SA, Kaplan HS (1969) The value of laparotomy and splenectomy in the staging of Hodgkin’s disease. Cancer 24: 709–718
Glatstein E, Kim H, Donaldson SS, Dorfman RF, Gribble TJ, Wilbur JR, Rosenberg SA, Kaplan HS (1974) Non-Hodgkin’s lymphomas. VI. Results of treatment in childhood. Cancer (Philadelphia) 34: 204
Glatstein E, Fuchs E, Goffinet DR, Kaplan HS (1976) Non-Hodgkin’s lymphoma of stage III extent. Is total lymphoid irradiation appropriate treatment? Cancer 37: 2806–2812
Glatstein E, Portlock C, Rosenberg SA, Kaplan HS (1977) Combined modality treatment in the malignant lymphomas. Salmon SE, Jones SE (eds). Elsevier/North Holland, Amsterdam, pp 545–548
Glick JH (1978) The treatment of stage III A Hodgkin’s disease: what is the role of combined modality therapy? Int J Radiat Oncol Biol Phys 4: 900–911
Goffinet DR, Castellino RA, Kim H, Dorfman RF, Fuks Z, Rosenberg SA, Nelson T, Kaplan HS (1973) Staging laparatomy in unselected previously untreated patients with Non-Hodgkin’s lymphomas. Cancer (Philadelphia) 32: 672–691
Goffinet DR, Glatstein E, Fuks Z, Kaplan HS (1976) Abdominal irradiation in Non-Hodgkin’s lymphomas. Cancer 37: 2797–2806
Gough J (1970) Hodgkin’s disease; a correlation of histopathology with survival. Int J Cancer 5: 273–281
Hamann W, Oehlert W, Musshoff K, Nuß A, Schnellbacher B (1970) Histologic classification of Hodgkin’s disease and its relevance to prognosis. Germ Med Monthly 15: 509–514
Han T, Stutzmann K (1967) Mode of spread in patients with localized malignant lym-phome. Arch Intern Med 120: 1–7
Hanks GE, Terry LN, Bryan JA, Newsome JF (1972) Contribution of diagnostic laparatomy to staging Non-Hodgkin’s lymphomas. Cancer (Philadelphia) 29: 41–43
Hausen zur H, Schulte-Holthausen H (1972) Detection of Epstein-Barr viral genomes in human tumor cells by nucleic acid hybridization. In: Biggs PM, de The G, Payne LN (eds) Oncogenesis and Herpesvirus. International Agency for Research on Cancer, Lyons, pp 321–325
Heilmeyer L, Begemann H (1961) Blut und Blutkrankheiten. In: Heilmeyer L (Hrsg) Lehrbuch der inneren Medizin, 2. Aufl. Springer, Berlin Göttingen Heidelberg, S 376–449
Hellman S, Mauch P, Goodman RL, Rosenthal DS, Molloney W (1978) The place of the radiation therapy in the treatment of Hodgkin’s disease. Cancer 42: 971–978
Hellstrom I, Hellstrom KE, Sjogren HD, Warner GA (1971) Demonstration of cell mediated immunity to human neoplasm of various histological types. Int J Cancer 7:1–6
Henle W, Henle G (1973) Evidence for an oncogenic potential of the Epstein-Barr virus. Cancer Res 33: 1419–1423
Hodgkin T (1832) On some morbid appearances of the absorbent gland and spleen. Med-Chir Trans 17: 68–114
Hoeffken K, Schmidt CG (1976) Laparoskopie bei Morbus Hodgkin. Dtsch Med Wschr 101: 814–818
Hohl K (1974) Present results in the treatment of malignant lymphomas. Results obtained in a series of 317 cases. In: Musshoff K (ed) Recent results in cancer research, vol 46. Springer, Berlin Heidelberg New York, pp 233–239
Jackson H, Parker F (1944) Hodgkin’s disease. I. General considerations. New Engl J Med 230: 1–8
Jackson H Jr, Parker F Jr (1947) Hodgkin’s disease and allied disorders. Oxford Univ Press, New York
Jeliff AM, Thomson AD (1955) The prognosis in Hodgkin’s disease. Brit J Cancer 9: 21–36
Johnson RE (1973) Total nodal irradiation. J Amer Med Ass 223: 59–61
Johnson RE (1975a) Total body irradiation (TBI) as primary therapy for advanced lymphosarcoma. Cancer (Philadelphia) 35: 242–246
Johnson RE (1975b) Management of generalized malignant lymphoma with “systemic” radiotherapy, Brit J Cancer 31, Suppl II: 450–455
Johnson RE, Rühl U (1976) Treatment of chronic lymphocytic leukemia with emphasis on total body irradiation. Int J Radiat Oncol Biol Phys 1: 387–397
Johnson RE, De Vita VT, Kun LE, Chabner BR, Chretin PB, Berard CW, Johnson SK (1975) Patterns of involvement with malignant lymphoma and implications for treatment decision making. Brit J Cancer 31, Suppl II: 237–241
Johnson RE, Glover MK, Marshall SK (1971) Results of radiation therapy and implications for the clinical staging of Hodgkin’s disease. Cancer Res 31:1834–1837
Johnson RE, Thomas LB, Schneider M, Glenn DW, Faw F, Hafermann MD (1970) Preliminary experience with total nodal irradiation in Hodgkin’s disease. Radiology 96: 603–608
Johnson RE, Rühl U, Brereton H (1975b) Radiation therapy of malignant lymphomas: Rationale techniques, results. Proceedings of the XI. International Cancer Congress, Florence 1974. Excerpta Medica International Congress Series 354: 374–379
Johnson RE, Rühl U. Johnson SK, Glover M (1976) Split-course radiotherapy of Hodgkin’s disease. Cancer 37: 1713–1717
Jones SE, Kaplan HS, Rosenberg SA (1972a) Non-Hodgkin’s lymphomas. III. Preliminary results of radiotherapy and a proposal for new clinical trials. Radiology 103: 657 – 662
Jones SE, Rosenberg SA, Kaplan HS (1972b) Non-Hodgkin’s lymphomas. I. Bone marrow involvement. Cancer (Philadelphia) 29: 954–960
Jones SE, Rosenberg SA, Kaplan HS, Kadin ME, Dorfman RF (1972c) Non-Hodkin’s lymphomas. II. Single agent chemotherapy. Cancer (Philadelphia) 30: 31–38
Jones SE, Fuchs Z, Bull M, Kadin ME, Dorfman RF, Kaplan HS, Rosenberg SA, Kim H (1973) Non-Hodkin’s lymphomas. IV. Clinicopathologic correlation in 405 cases. Cancer (Philadelphia) 31: 806–825
Jones SE, Godden J (eds) (1977) Proceecdings of the Conference on Non-Hodgkin’s Lymphomas. September 30 to October 2, 1976, San Francisco, California. Cancer Treat Rep 61: 935–1227
Kaplan HS (1962) The radical radiotherapy of regionally localized Hodgkin’s disease. Radiology 78: 533–561
Kaplan HS (1966) Evidence for a tumoricidal dose level in the radiotherapy of Hodgkin’s disease. Cancer Res 26: 1221–1224
Kaplan HS (1968) Prognostic significance of the relapse free Intervall after radiotherapy in Hodgkin’s disease. Cancer (Philadelphia) 22: 1131–1136
Kaplan HS (1968–1969) On the natural history, treatment and prognosis of Hodgkin’s disease. The Harvey Lectures, Series 64: 215–259. Academic Press, New York, 1970
Kaplan HS (1972) Hodgkin’s disease. Harvard Univ. Press, Cambridge/Massachusetts
Kaplan HS (1973) Radiotherapy of advanced Hodgkin’s disease with curative intent. In: Rubin P (ed) Updated Hodgkin’s disease: B. Curability of localized disease. J Amer Med Ass 223: 50–52
Kaplan HS (1978) In: Harvey AG, Kagan AR (eds) Modern radiation oncology: Hodgkin’s lymphomas commentary. Harper & Row, Haberstown New York San Francisco London, pp 418–427
Kaplan HS, Dorfman RF, Nelsen TS, Rosenberg SA (1973) Staging laparotomy and splenectomy in Hodgkin’s disease. Analysis of indications and patterns of involvement in 285 consecutive unselected patients. Nat Cancer Inst Monogr 36: 291–301
Kaplan HS, Dorfman RF, Nelsen TS, Rosenberg SA (1974) Staging laparotomy and splenectomy in Hodgkin’s disease. Analysis of indications and patterns of involvement in 285 consecutiveunselected cases. In: Musshoff K (ed) Recent results in cancer research, vol 46. Springer, Berlin Heidelberg New York, pp 118–122
Keller AR, Kaplan HS, Lukes RJ, Rappaport H (1968) Correlation of histopathology with other prognostic indicators in Hodgkin’s disease. Cancer (Philadelphia) 22: 487–499
Klaue P, Gunzer U, Nürnberger R (1974) Operationsrisiko und diagnostischer Wert der explorativen Laparotomie und Splenektomie bei Morbus Hodgkin. Chirurg 45: 421–425
Kleihauer Ü (1978) Hämatologie — Physiologie — Pathologie -Klinik. Springer, Berlin Heidelberg New York
Klein G, Clifford G, Henle G, et al (1969) EBV-associated serological patterns in a Burkitt lymphoma patient during regression and recurrence. Int J Cancer 4: 416–421
Koppenfels R v (1971) Klinische Erfahrungen im Plasmozytom unter besonderer Berücksichtigung der Röntgendiagnostik und der Strahlentherapie. Strahlentherapie 142: 276–285
Kubik S (1974) The anatomy of the lymphatic system. In: Musshoff K (ed) Recent results in cancer research, vol 46. Springer, Berlin Heidleberg New York, pp 233–239
Landberg T (1974) Radiosensitivity problems in mantle treatment of Hodkin’s disease, In: Lopez GJ, Monmati J, Berry RH, Hopewell JW (eds) Proceedings of the XIII. International Congress of Radiology, Madrid, October 15–20, 1973. Radiology 2: 115–116. Excerpta Medica, Amsterdam
Landberg T, Forslo H (1970) Radiosensitivity of mediastinal lymphomas in Hodgkin’s disease treated with split-course radiotherapy. Acta Radiol Ther Phys Biol 9: 177–189
Landberg T, Larsson LE (1969) Hodgkin’s disease. Retrospective clinico-pathologic study in 149 patients. Acta Radiol (Stockholm) 8: 390–414
Landberg T, Garwicz S, Ackerman M (1975) A clinico-pathological study of Non-Hodg-kin’s lymphomata in childhood. Brit J Cancer 31, Suppl II: 332–336
Lattuada A, Bonadonna G, Milani F, Banfi A, Valagussa P, De Lena M, Monfardini S (1977) Adjuvant chemotherapy with CVP after radiotherapy (RT) in stage I-II Non-Hodkin’s lymphomas. In: Salmon SE, Jones SE (eds) Adjuvant therapy of cancer. Elsevier/North Holland, Amsterdam
Leibfried H, Kerssenfischer V, Fiss N, Werner S (1975) Prognost. Untersuchung. Medizin Technik, Basel
Lennert K (1953) Histologische Studien zur Lymphogranulomatose. I. Die Cytologie der Lymphogranulomzellen. Frankfurt Z Path 64: 209–234
Lennert K (1967) Classification of malignant lymphomas (European Concept). In: Rüttimann A (ed) Progress in lymphology. Thieme, Stuttgart, pp 103–109
Lennert K (1969) Pathologisch-anatomische Klassifikation der malignen Lymphome. In: Becker J, Gauwerky F (Hrsg) Maligne Lymphome. Urban & Schwarzenberg, München Berlin Wien
Lennert K (1973a) Pathologisch-histologische Klassifizierung der malignen Lymphome, Pathophysiologie, Klinik, Chemo- und Immuntherapie. Stacher A (Hrsg). Urban & Schwarzenberg, München Berlin Wien, S 181–1994
Lennert K (1973b) Follicular lymphoma. A tumor of the germinal centers. In: Akazaki K, Rappaport H, Berard CW, Bennett JM, Ishikawa E (eds) Malignant diseases of the hematopoietic system. GANN Monograph on Cancer Research, vol 15. University of Tokyo Press, Tokyo, pp 217–231
Lennert K (1976) Klassifikation und Morphologie der Non-Hodgkin-Lymphome. In: Löffler H (Hrsg) Maligne Lymphome und monoklonale Gammopathien. Hämatologie und Bluttransfusion, Bd. 18. Lehmann, München, S 145–150
Lennert K, Stein H, Kaiserling E (1975) Cytological and functional criteria for the classification of malignant lymphoma. Brit J Cancer 31, Suppl II: 29–43
Lennert K, in collaboration with Mohri N, Stein H, Kaiserling E, Müller-Hermelink HK (1978) Malignant lymphomas other than Hodgkin’s disease. In: Handbuch der speziellen pathologischen Anatomie und Histologie, Bd I/3B. Springer, Berlin Heidelberg New York
Levi JA, Wiernik PH (1977) The therapeutic implications of splenic involvement in stage III A Hodgkin’s disease. Cancer 39: 2158–2165
Lewitt SH, Bloomfield CD, Lee CKK, Nesbit ME, McKenna RW (1976) Extended field radiotherapy in Non-Hodgkin’s lymphoma. Radiology 118: 457–459
Li JG (1963) The leukocytopenic effect of focal splenic X-irradiation in leukemic patients. Radiology 80: 471–476
Lichtenstein L (1953) Histiocytosis X: integration of eosinophilic granuloma of bone, Letterer-Siwe disease and Hand-Schüller-Christian disease. As related manifestations of single nosologic entity. AMA Arch Path 56: 84–102
Lichtenstein L, Jaffe HL (1940) Eosinophilic granuloma of bone. Amer J Path 16: 595–604
Lokich JJ, Frei III E, Jaffe N, Tullis J (1976) New multiple-agent chemotherapy (B-DOPA) for advanced Hodgkin’s disease. Cancer 38: 667–671
Lourdes Z, Nisce G, D’Angio J, Kim JH (1973) Weekly total-skin electron-beam irradiation for mycosis fungoid es. Radiology 109: 638–686
Lowenbraun S, Sutherland IC, Feldman MJ, Serpick AA (1971) Transformation of reticulum cell sarcoma to acute leukemia. Cancer (Philadelphia) 27: 579–585
Lukes RJ (1963) Relationship of histologic features to clinical stages in Hodgkin’s disease. Amer J Roentgenol 90: 944–955
Lukes RJ (1968) The pathologic picture of the malignant lymphomas. In: Zarafonatis CJD (ed) Proceedings of the International Conference on Leukemia-Lymphoma. Lea & Febiger, Philadelphia, pp 333–356
Lukes RJ, Butler JJ (1966) The pathology and nomenclature of Hodgkin’s disease. Cancer Res 26: 1063–1081
Lukes RJ, Butler JJ, Hicks EB (1966a) Natural history of Hodgkin’s disease as related to its pathologic picture. Cancer (Philadelphia) 19: 317–344
Lukes RJ, Collins RD (1974) Functional approach to the classification of malignant lymphoma. In: Musshoff K (ed) Recent results in cancer research, vol 46. Springer, Berlin Heidelberg New York, pp 19–30
Lukes RJ, Collins RD (1975) New approaches to the classification of the lymphomata. Brit J Cancer 31: 1–28
Lukes RJ, Craver LF, Hall TC, Rappaport H, Rubin P (1966b) Report of the nomenclature comittee. Cancer Res 26: 1311
MacMahon B (1957) Epidemiological evidence on the nature of Hodgkin’s disease. Cancer (Philadlephia) 10: 1045–1054
McKelvey EM, Moon TE (1977) Curability of Non-Hodgkin’s lymphomas. Cancer Treat Rep 61: 1185–1190
Meuret G, Hoffmann G, Gmelin R (1975) Erfahrungen mit der Radiophosphor-Therapie bei Polycythaemia vera. Strahlentherapie 149: 49–54
Meuret G, Fliedner TM, Schütz W, Öhl N, Afkham J, Obrecht P, Musshoff K (1971) Erfahrungen mit der extrakorporalen Blutbestrahlung bei der Behandlung der chronisch-lymphatischen Leukämie. Klin Wochenschr 49: 899–904
Meuret G, Schütz W, Harris EB, Fliedner TM, Hoelzer D, Afkham J, Obrecht P, Musshoff K, Heinze V. Tourkantonis A (1969) Die Behandlung der chronisch-lymphatischen Leukämie durch extrakorporale Blutbestrahlung unter Verwendung konventioneller Strahlentherapiegeräte. Strahlentherapie 137: 429–441
Meusers R, Bartels H, Brittinger G, Common H, Dühmke E, Fülle HH, Gunzer U, Heinz R, König E, Musshoff K, Pralle H, Schmalhorst U, Theml H, Krüger GRF, Lennert K (1979) Heterogenity of diffuse histiocytic lymphoma as demonstrated by the Kiel Classification. N Engl J Med: 384
Mill WB (1975) Radiation therapy in multiple myeloma. Radiology 115: 175–178
Moore MR, Bull JM, Jones SE, Rosenberg SA, Kaplan HS (1977) Sequential radiotherapy and chemotherapy in the treatment of Hodgkin’s disease: a progress report. Ann Intern Med 77: 1–9
Moss WT, Brand WN, Battifora H (1973) Radiation oncology. Rationale, technique results, 4th ed. Mosby, St. Louis
Murphy SB (1976) Non-Hodgkin’s lymphomas of childhood. In: Donaldson M, Sendel HG (eds) Trends in childhood cancer. Wiley, New York, p 31
Murphy SB (1977) Management of childhood Non-Hodkin’s lymphoma. Cancer Treat Rep 61: 1161–1173
Musshoff K (1967) Systematische prophylaktische Bestrahlung bei Systemerkrankungen (Morbus Hodgkin). Strahlentherapie Sonderbd 64, Teil B: 74–86
Musshoff K (1968) Die Strahlentherapie der Leukosen. Internist 9: 484–489
Musshoff K (1971) Prognostic and therapeutic implications of staging in extranodal Hodgkin’s disease. Cancer Res 31: 1814–1827
Musshoff K (1972) Grundlagen der Strahlentherapie des Morbus Hodgkin. Indikation und Ergebnisse. Z Krebsforsch 78: 162–191
Musshoff K (1973) Survival and relapse data in Hodgkin’s disease. Freiburg im Breisgau 1948–1969. Int Symp Hodgkin’s disease, Stanford University School of Medicine, Stanford, Calif., March 20–24, 1972. Nat Cancer Inst Monogr 36: 531–539
Musshoff K (1978) Voraussetzungen und Probleme der adjuvanten Chemotherapie in Verbindung mit der primären Strahlentherapie der Nicht-Hodgkin-Lymphome unter besonderer Berücksichtigung der Histologie. Hämatologie Bluttransfusion 22: 101–114
Musshoff K (1979) Die Strahlentherapie der Non-Hodgkin-Lymphome. Indikation und Probleme. In: Stacher A, Höcker P (Hrsg) Lymphknotentumoren. Urban & Schwar-zenberg, München Wien Baltimore, S 157–165
Musshoff K, Boutis L (1967) Die Frage der Heilbarkeit der Lymphogranulomatose, beurteilt nach den Behandlungsergebnissen der Freiburger Medzinischen Klinik. Verh Dtsch Ges Inn Med 73: 322–329
Musshoff K, Boutis L (1968) Therapy results in Hodgkin’s disease. Freiburg i.Br., 1948–1966. Cancer 21: 1100–1113
Musshoff K, Leopold H (1978) On the question of the tumoricidal dose in Non-Hodgkin’s lymphomas. In: Mathé G, Seligmann M, Tubiana M (eds) Recent results in cancer research, vol 65. Springer, Berlin Heidelberg New York, S. 203–206
Musshoff K, Schmidt-Vollmer H (1975a) Prognostic significance of primary site after radiotherapy in Non-Hodkin’s lymphomata. Brit J Cancer 31, Suppl II: 425–434
Musshoff K, Schmidt-Vollmer H (1975b) Prognosis of Non-Hodgkin’s lymphomas with special emphasis on the staging classification. Z Krebsforsch 83: 323–341
Musshoff K, Slanina J (1974a) Die Strahlenbehandlung der Lymphogranulomatose. Internist 15: 85–92
Musshoff K, Slanina J (1974b) Stadieneinteilung der malignen Lymphome — zugleich ein Beitrag über die Bedeutung der Laparatomie mit Splenektomie. Klin Wochenschr 52: 109–117
Musshoff K, Stamm H, Lümmel G, Gössel K (1964) Zur Prognose der Lymphogranulomatose. Klinisches Bild und Strahlentherapie. Freiburger Krankengut 1938–1958. Beiträge zur inneren Medizin. Schattauer, Stuttgart, S. 549–561
Musshoff K, Boutis L, Obrecht P, Karsch T (1968a) Die Lebenserwartung bei der chronischen myeloischen Leukaemie in Abhängigkeit von der Therapie. Freiburger Ergebnisse 1945–1966. Verh Dtsch Ges Inn Med 74: 648–652
Musshoff K, Renemann H, Boutis L, Afkham J (1968b) Die extranoduläre Lymphogranulomatose: Diagnose, Therapie und Prognose bei zwei unterschiedlichen Formen des Organbefalls. Ein Beitrag zur Stadieneinteilung des Morbus Hodgkin. Fort sehr Röntgenstr 104: 776–786
Musshoff K, Boutis L, Obrecht P, Karsch T (1969) Die Lebenserwartung der chronischen myeloischen Leukaemie in Abhängigkeit von individuellen und krankheitsspezifischen Faktoren und der Therapie. Freiburger Ergebnisse 1947–66. Klin Wschr 47: 179–183
Musshoff K, Oehlert W, Hamann W, Nuss A (1970a) Radiation therapy and cure in Hodgkin’s disease. Acta Radiol Ther Phys Biol 9: 289–301
Musshoff K, Renemann H, Boutis L, Afkham J (1970b) The differentiation of two different types of stage IV of Hodgkin’s disease. II. International Congress of Lymphol-ogy, Miami, March 15–20, 1968. Progress in Lymphology II. Thieme, Stuttgart, pp 272–275
Musshoff K, Schmidt-Vollmer H, Merten D (1971) Reticulum cell sarcoma: An onocological model for a system of classifying the malignant lymphoma. Europ J Cancer 7: 451–457
Musshoff K, Hartmann C, Niklaus B, Rossner R (1974a) Results of therapy in Hodgkin’s disease. Freiburg i. Br. 1964–1971. In: Musshoff K (ed) Recent results in cancer research, vol 46. Springer, Berlin Heidelberg New York, pp 206–220
Musshoff K, Hartmann CHG, Niklaus B, Rossner R (1974b) Prognostic value of the survival, remission, and recurrence rates of Hodgkin’s disease following radiation therapy. In: Lopez GH, Bonmati J, Berry RH, Hopewell JW (eds) Radiology. Proceedings of the XIII. International Congress of Radiology, Madrid, October 15–20, 1973. Excerpta Medica, Amsterdam; American Elsevier, New York, pp 7–10
Musshoff K, Staib J, Oehlert W, Pauli-Beisel C, Löhr G-W, Slanina J, Böttcher D (1974c) Primäre und sekundäre Laparotomie mit Splenektomie bei Patienten mit Morbus Hodgkin. Vorläufige Ergebnisse im Freiburger Krankengut. Klin Wochenschr 52: 24–29
Musshoff K, Hartmann C, Niklaus B, Rossner R (1976) The prognostic significance of first and second remission in Hodgkin’s disease after first and second relapse radiotherapy. Z Krebsforsch 85: 243–270
Musshoff K, Schmidt-Vollmer H, Lennert K, Sandritter W (1976) Preliminary clinical findings on the Kiel Classification of malignant lymphomas. Z Krebsforsch 87: 229–238
Musshoff K, Stotzingen W von, Schmidt-Vollmer H (eingereicht) Investigation results of a comparison between the Rappaport and the Kiel Classification of the non-Hodgkin lymphomas, together with clinical data. J Cancer Res Clin Oncol
Neidhart B, Hartwich G, Schwemmle K, Hermanek P, Seiler G (1975) Explorative Lapa-ratomie und Splenektomie bei Lymphogranulomatose. Dtsch Med Wochenschr 100: 1487–1492
Ochsner SF (1966) Eosinophile granuloma of bone. Experience with 20 cases. Amer J Roentgenol 97: 719–726
O’Connell MJ, Wiernik PH, Brace KC, Byhardt RW, Green WH (1975) A combined modality approach to the treatment of Hodgkin’s disease; preliminary results of a prospectively randomized clinical trial. Cancer 35: 1055–1064
Olmer J, Gabriel B, Bove J (1967) Zur Behandlung der chronischen myeloischen Leu-kaemie. Dtsch Röntgenkongreß 1966, Teil B, S 276–277
Ottani S, Ehrlich JC (1940) Solitary granuloma of bone simulating primary neoplasm. Amer J Pathol 16: 479–490
Page V, Gardner A, Karzmark CJ (1970a) Physical and dosimetric aspects of the radiotherapy of malignant lymphomas. The mantle technique. Radiology 96: 609–618
Page V, Gardner A, Karzmark C (1970b) Physical and dosimetric aspects of the radiotherapy of malignant lymphomas. II. The inverted Y-technique. Radiology 96: 619 – 626
Peckham MJ (ed) (1975) Non-Hodgkin’s lymphomata, Symposium held at the Royal Institution, London, October 1973. Brit J Cancer 31, Suppl II
Peters MV (1950) A study of survivals in Hodgkin’s disease treated radiologically. Amer J Roentgenol 63: 299–311
Peters MV (1961) The place of irradiation in the control of Hodgkin’s disease. In: Proceedings of the IV. National Cancer Conference 1960. Lippincott, Philadelphia, pp 571–584
Peters MV (1966) Prophylactic treatment of adjacent areas in Hodgkin’s disease. Cancer Res 26: 1232–1243
Peters MV, Brown TC, Rideout DF (1973) Prognostic influences and radiation therapy according to pattern of disease. In: Rubin P (ed) Updated Hodgkin’s disease: B. Curability of localized disease. J Amer Med Ass 223: 53–58
Peters MV, Hasselback R, Brown TC (1968) The natural history of the lymphomas related to the clinical classification. In: Zararonetis CJD (ed) Proceedings of the International Conference on Leukemia-Lymphoma. Lea & Febiger, Philadelphia, pp 357–370
Peters MV, Bush RS, Brown TC, Reid J (1975) The place of radiotherapy in the control of non-Hodgkin’s lymphomata. Brit J Cancer 31, Suppl II: 386–401
Peters MV, Middlemiss KCH (1958) Study of Hodgkin’s disease treated by irradiation. Amer J Roentgenol 79: 114–121
Pfeiffer J (1965) Zur Diagnostik und Therapie des eosinophilen Knochengranuloms. Strahlentherapie 126: 42–52
Pinkel D, Somone J, Hustu HO, Aur RJA (1972) Nine years experience with “total therapy” of childhood acute lymphocytic leukemia. Pediatrics 50: 246–251
Pinkel D, Johnson W, Aur RJA (1975) Non-Hodgkin’s lymphoma in children. Brit J Cancer 31, Suppl II: 298–323
Portlock CS, Rosenberg SA, Glatstein E, Levy R, Kaplan HS (1977) Failure of initial therapy for stage I, II and III Hodgkin’s disease: salvage management (Abstr). Proc Amer Soc Clin Oncol 18: 342
Porzig KJ, Portlock CS, Robertson A, Rosenberg SA (1978) Treatment of advanced Hodgkin’s disease with B-CAVe following MOPP failure. Cancer 41: 1670–1675
Prager PJ, Menges V, DiBiase M, Wurster KH, Krastel A, Assmus H (1976) Das eosinophile Knochengranulom beim Erwachsenen. Radiologe 16: 21–28
Prosnitz LR, Rafael L, Montalvol BA, Fischer DB, Silberstein AB, Berger DS (1978) Treatment of stage III A Hodgkin’s disease: Is radiotherapy alone adequate? Int J Radiat Oncol Biol Phys 4: 781 – 787
Rai KR, Sawithky A, Cronkite EP, Chanana AD, Levy RN, Pasternack BS (1975) Clinical staging of chronic lymphocytic leukemia. Blood 46: 219–234
Rajewski B (1954) Strahlendosis und Strahlenanwendung. Thieme, Stuttgart
Rappaport H (1966) Tumors of the hematopoetic system. Armed Forces Institute of Pathology, Sect 3, fase 8. Washington DC, pp 91–156
Pappaport H, Strum SB (1970) Vascular invasion in Hodgkin’s disease: Its incidence and relationship to the spread of the disease. Cancer (Philadlephia) 25: 1304–1313
Rappaport H, Winter WJ, Hicks EB (1956) Follicular lymphoma: A reevaluation of its position in the scheme of malignant lymphomas, based on a survey of 253 cases. Cancer (Philadelphia) 9: 729–821
Ratkóczy N (1936) Herdvernichtungsdosen in der Röntgentherapie der Lymphogranulomatose. Strahlentherapie 56: 325–336
Renner H (1973) Strahlentherapeutische Aspekte des multiplen Myeloms. Strahlentherapie 146: 15–23
Revol L, Cordat M, Rouhier D, Clavel M, Jeune R, Guyon JM, Chassard JL, Papillon J (1974) Quelques considération sur la radiothérapie dans la leucémie myéloide chronique. Strahlentherapie 148: 572–578
Riehm H, Gadner H, Weite K (1977) Die West-Berliner Studie zur Behandlung der akuten lymphoblastischen Leukämie des Kindes — Erfahrungsbericht nach 6 Jahren. Klin Pädiat 189: 89–102
Robb-Smith AHT (1947) The lymph node biopsy. In: Recent advances in clinical pathology. Churchill, London, pp 350–370
Rosenberg SA (1961) Lymphosarcoma: A review of 1269 cases. Medicine (Baltimore) 40: 31–84
Rosenberg SA (1966) Report of the Staging Committee of Hodgkin’s disease. Cancer Res 26: 1310
Rosenberg SA, Kaplan HS (1966) Evidence for an orderly progression in the spread of Hodgkin’s disease. Cancer Res 26: 1225–1230
Rosenberg SA, Kaplan HS (1970) Hodgkin’s disease and other malignant lymphomas. Calif Med 113: 23–38
Rosenberg SA, Kaplan HS (1975a) The management of stage I, II and HI Hodgkin’s disease with combined radiotherapy and chemotherapy. Cancer (Philadelphia) 35: 55–63
Rosenberg SA, Kaplan HS (1975b) Clinical trials in the non-Hodkin’s lymphomata at Stanford University experimental design and preliminary results. Brit J Cancer 31, Suppl II: 456–464
Rosenberg SA, Boiron M, DeVita VT, Johnson RE, Lee BJ, Ullmann JE, Viamonte M (1971) Report of the Committee on Hodgkin’s disease staging procedures. Cancer Res 31: 1862–1863
Rosenberg SA, Kaplan HS, Glatstein E, Portlock SC (1977) The role of adjuvant MOPP in the radiation therapy of Hodgkin’s disease: a progress report after eight years on the Stanford trials. In: Salmon SE, Jones SE (eds) Adjuvant therapy of cancer. Elsevier/North Holland, Amsterdam, pp 505–515
Rosenberg SA, Kaplan HS, Glatstein EJ, Portlock CS (1978) Combined modality therapy of Hodgkin’s disease — Report of the Stanford trials. Cancer 42: 991–1000
Rosenthal SR (1936) Significance of tissue lymphocytes in the prognosis of Lymphogranulomatose. Arch Path 21: 628–646
Rous P (1911) Transmission of a malignant new growth by means of cell-free filtrate. J Amer Med Ass 56: 198–201
Rühl U (1977) Ganzkörperbestrahlung bei Non-Hodgkin-Lymphomen als Alternative zur Chemotherapie. Strahlentherapie 153: 299–303
Rühl U, Johnson RE (1975) Ganzkörperbestrahlung in der Behandlung der chronischen Lymphadenose. Vortrag; Deutsch-Österr. Hämatologen-Kongreß, Bad Nauheim
Salzmann JR, Kaplan HS (1971) Effect of splenectomy on hematologic tolerance during total lymphoid radiotherapy of patients with Hodgkin’s disease. Cancer 27: 471–478
Schein PS, Chabner BA, Canellos GP, Young RC, DeVita VT Jr (1975) Non-Hodgkin’s lymphoma: Patterns of relapse from complete remission after combination chemotherapy. Cancer 35: 354–357
Schmidt-Vollmer H, Musshoff K, Lennert K, Sandritter W, Stiefelhaben H (1975) Vorläufige Befunde zur Prognose der Kiel-Klassifikation der malignen Non-Hodgkin-Lymphome. Gemeinsame Tagung der Deutschen und Österreichischen Gesellschaft für Hämatologie, Bad Nauheim, 29.9–1.10.1975
Schmitz H, Scherer H (1972) IgM antibodies to Epstein-Barr virus in infectious mononucleosis. Arch Ges Virusforsch 37: 332–339
Schoen D, Bauer R (1968) Ergebnisse der Milzbestrahlung bei 175 Fällen mit chronisch-myeloischer Leukämie. Strahlentherapie 135: 1–10
Scott RB (1957) Leukaemia: chronic lymphatic leukaemia. Lancet 1957 I: 1162–1167
Sherins RJ, DeVita VT Jr (1973) Effect of drug treatment for lymphoma on male reproductive capacity. Studies of men in remission after therapy. Ann Intern Med 79: 216–220
Slanina J, Musshoff K, Rahner T, Stiassny R, in cooperation with: Barmeyer J, Baumeister L, Berger W, Dichgans J, Gehring G, Grub R, Heite H-J, Hennekeuser HH, Herkel L, Krüssmann K, Kuphal K, Löhr G-W, Möbius W, Rossner R, Schmidt-Vollmer H (1977) Long-term side effects in irradiated patients with Hodgkin’s disease. Int J Radiat Oncol Biol Phvs 2: 1–19
Slanina J, Kuphal K, Riegsinger A (1980) Anwendung des Split-Course-Verfahrens bei der total nodalen Systembestrahlung der Hodgkin’schen Erkrankung. Strahlentherapie 156: 18–25
Smetana HF, Cohen BM (1956) Mortality in relation to histologic type in Hodgkin’s disease. Blood 11: 211 – 224
Speck B (1975) Möglichkeiten und Probleme der klinischen Knochenmarkstransplantation. Med Welt (Berlin) 26: 39–43
Spiegelman S, Axel R, Baxt W, Jufe D, Schlom J (1974) Human cancer and animal viral oncology. Cancer (Philadelphia) 34: 1406–1420
Stacher A, Theml H, Waldner R (1975) Klinik der malignen Non-Hodgkin-Lymphome entsprechend der Kieler Klassifikation: Immunocytom und chronische lymphatische Leukämie. Gemeinsame Tagung der Deutschen und Österreichischen Gesellschaft für Hämatologie, Bad Nauheim, 29.9.–1.10.1975
Stein H (1976) Klassifikation der malignen Non-Hodgkin-Lymphome aufgrund gemeinsamer morphologischer und immunologischer Merkmale zwischen normalen und neoplastischen Zellen. Immun Infekt 4: 52–69 und 95–109
Stein RS, Hilborn RM, Flexner JM, Bolin M, Stroup S, Reynolds V, Krantz S (1978) Anatomical sub stages of stage III Hodgkin’s disease. Implications for staging, therapy and experimental design. Cancer 42: 429–436
Stenfert-Kroese WF, Cleton FJ, Somers R (1974) Leukaemic progression in lympho-mata. Symposium on Non-Hodgkin’s lymphomata. London, October 8–10 1973. Brit J Cancer 30, Suppl II: 102–106
Strauchen JA, Young RC, DeVita VT Jr, Anderson T, Fantone YC, Berard CW (1978) Clinical relevance of the histopathological sub classificai ion of diffuse “histocytic” lymphome. New Engl J Med 299: 1382–1387
Strickstrock KH, Musshoff K, Boutis L (1967) Methode der zusätzlichen prophylaktischen Bestrahlung bei der Lymphogranulomatose. Strahlentherapie 133: 337–348
Symposium International organisé à Paris de 15 Février 1965 sous la direction de M. Maurice Tubiana: La radiothérapie de la maladie de Hodgkin. J Radiologie, Suppl 47: 1–176
Symposium (1971) Staging in Hodgkin’s disease. Ann Arbor/Michigan, April 26–28, 1971. Cancer Res 31: 1707–1870
Symposium International on Hodgkin’s disease (1973) Stanford (Calif), March 20–24, 1972. Natl Cancer Inst Monogr 36: 1 – 587
Symposium on Non-Hodgkin’s lymphomata (1975) London, October 8–12, 1973. Pckham MJ (ed). Brit J Cancer 30, Suppl II: 1–511
Teschendorf W (1927) Über Bestrahlung des ganzen menschlichen Körpers bei Blutkrankheiten. Strahlentherapie 26: 720–728
Tschendorf W (1953) Die Teleröntgentherapie. Thieme, Stuttgart
Thomas ED, Buckner CD, Banaji M, Clift RA, Fefer A, Flournoy N, Goodell BW, Hickman RO, Lerner KG, Neiman PE, Sale GE, Sanders JE, Singer J, Stevens M, Storb R, Weiden PL (1977) One hundred patients with acute leukemia treated by chemotherapy, total body irradiation and allogeneic marrow transplantation. Blood 49: 511 – 533
Todd IDH (1965) Treatment of solitary plasmacytoma. Klin Radiol 16: 385–399
Töppner R (1952) Zur Behandlung des eosinophilen Granulomes mit Röntgenstrahlen. Strahlentherapie 88: 362–376
Tubiana M, Attie E, Flamant R, Gerard-Marchant R, Hayat M (1971) Prognostic factors in 454 cases of Hodgkin’s disease. Cancer Res 31: 1801–1810
Tulinius H (1974) Epidemiology of Hodgkin’s disease. XI. International Cancer Congress, Florence, October 20–26, 1974
Veronesi U. Musumeci R, Pizzetti F, Gennari L, Bonadonna G (1974) The value of staging laparotomy in Non-Hodgkin’s lymphomas. Cancer (Philadelphia) 33: 446–459
Vianna NJ, Koegh MD, Polan AK, Greenwald P (1974) Hodgkin’s disease mortality among physicians. Lancet 1974 II: 131–132
Wachtler F (1961) Über die Strahlenbehandlung des eosinophilen Knochengranuloms. Krebsarzt 16: 193–197
Wannenmacher M, Slanina J, Kuphal K, Bruggmoser G (1978) Gegenwärtiger Stand der Großfeldtechnik unter Megavoltbedinungen bei der Strahlentherapie der Hodgkin’-schen Erkrankung — Grundlagen, Durchführung, Nebenwirkungen. Radiologe 18: 371–387
Watanabe A, Sullivan MP, Sutow WW, Wilbur R (1973) Undifferentiated lymphoma of non-Burkitt’s type. Amer J Dis Child 125: 57–61
Wehinger H, Slanina J, Jacobi H, Musshoff K, Dietz V, Sauer M, Dilger M (1974) Prophylactic central nervous system therapy with cranial irradiation and intrathecal methotrexate in acute lymphoblastic leukaemia of childhood. Strahlentherapie 148: 590–598
Weller S, Glatstein E, Castellino RA, Kaplan HS, Rosenberg SA (1977) Initial relapse in previously treated Hodgkin’s disease. — II. Retrograde transdiaphragmatic extension. Int J Radiat Oncol Biol Phys 2: 863–872
Werf-Messing B van der (1968) Reticulum cell sarcoma and lymphosarcoma. A retrospective study of potential survival in loco-regional disease. Europ J Cancer 4: 549 – 557
Worthy TS (1975) The place of laparotomy in the cure of Hodgkin’s disease. 3. Kongreß der Europäischen Radiologischen Gesellschaft, Edinburgh, 22.–27. Juni 1975
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1980 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Musshoff, K., Slanina, J. (1980). Maligne Systemerkrankungen. In: Scherer, E. (eds) Strahlentherapie. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-96542-5_14
Download citation
DOI: https://doi.org/10.1007/978-3-642-96542-5_14
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-540-09780-8
Online ISBN: 978-3-642-96542-5
eBook Packages: Springer Book Archive